首页> 外国专利> Screening donor hematopoietic cell transplantation, expected, a method of identifying, kits and arrays, as well as a method of hematopoietic cells transplantation (HCT) to predict the risk of causing graft-versus-host disease (GVHD), kits and arrays

Screening donor hematopoietic cell transplantation, expected, a method of identifying, kits and arrays, as well as a method of hematopoietic cells transplantation (HCT) to predict the risk of causing graft-versus-host disease (GVHD), kits and arrays

机译:筛选预期的供体造血细胞移植,鉴定,试剂盒和阵列的方法,以及预测导致移植物抗宿主病(GVHD)的风险的造血细胞移植(HCT)的方法,试剂盒和阵列

摘要

The present invention, hematopoietic cell transplantation from a donor (HCT) is to predict or determine the risk of causing graft-versus-host disease (GVHD) in HCT recipient from a donor candidates, depending on the risk of causing GVHD in HCT recipients to classify the HCT, and one or organizational structure that are classified or scoring depending HCT of multiple donor candidates to the risk of causing GVHD in HCT recipients (for example, database) and organizational structure (for example, database ) method for the production of. The present invention can also be used to predict or determine the risk of causing GVHD in HCT is HCT recipient from a donor candidates, and kits useful for classifying or scoring the donor depending on the risk of causing GVHD in HCT recipients and on the array.
机译:本发明,来自供体的造血细胞移植(HCT)是用来预测或确定来自供体候选者的HCT接受者中引起移植物抗宿主病(GVHD)的风险,这取决于使HCT接受者产生GVHD的风险。对HCT进行分类,并根据多个供体候选者的HCT对产生HV受体的GVHD风险(例如数据库)和组织结构(例如数据库)的生产方法进行分类或评分,以对多个供体候选者进行分类或评分。本发明还可用于预测或确定来自供体候选者的HCT接受者在HCT中引起GVHD的风险,并且试剂盒可用于根据在HCT接受者和阵列中引起GVHD的风险来对供体进行分类或评分。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号